We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$25B
AUM Growth
+$2.37B
Cap. Flow
+$1.17B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$804M
2
ACN icon
Accenture
ACN
+$118M
3
SYY icon
Sysco
SYY
+$76.9M
4
AAPL icon
Apple
AAPL
+$76.7M
5
NTAP icon
NetApp
NTAP
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Healthcare 13.03%
3 Financials 12.46%
4 Consumer Discretionary 10.73%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRKL
976
DELISTED
Brookline Bancorp
BRKL
$205K ﹤0.01%
12,311
+1,003
+9% +$18.2K
STBA icon
977
S&T Bancorp
STBA
$1.88B
$205K ﹤0.01%
4,750
+112
+2% +$5.07K
COUP
978
DELISTED
Coupa Software Incorporated
COUP
$205K ﹤0.01%
2,595
+230
+10% +$16K
TLP
979
DELISTED
Transmontaigne
TLP
$205K ﹤0.01%
5,350
-300
-5% -$11.6K
SONC
980
DELISTED
Sonic Corp
SONC
$205K ﹤0.01%
4,742
+108
+2% +$3.88K
MED icon
981
Medifast
MED
$110M
$204K ﹤0.01%
925
+459
+98% +$93.1K
THO icon
982
Thor Industries
THO
$3.98B
$204K ﹤0.01%
2,452
-4,832
-66% -$462K
AEM icon
983
Agnico Eagle Mines
AEM
$73B
$203K ﹤0.01%
5,964
-2,145
-26% -$83.5K
PCSB
984
DELISTED
PCSB Financial Corporation
PCSB
$203K ﹤0.01%
10,000
STMP
985
DELISTED
Stamps.com, Inc.
STMP
$202K ﹤0.01%
897
-511
-36% -$128K
LNT icon
986
Alliant Energy
LNT
$19.1B
$201K ﹤0.01%
4,730
-264
-5% -$11.3K
SXI icon
987
Standex International
SXI
$3.75B
$200K ﹤0.01%
1,929
+145
+8% +$15.4K
ATO icon
988
Atmos Energy
ATO
$29.7B
$199K ﹤0.01%
2,132
-997
-32% -$92K
S
989
DELISTED
Sprint Corporation
S
$199K ﹤0.01%
30,456
-10,968
-26% -$65.2K
MFGP
990
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$199K ﹤0.01%
8,935
-3,034
-25% -$61.6K
COHR
991
DELISTED
Coherent Inc
COHR
$198K ﹤0.01%
1,154
+114
+11% +$20.1K
AVAV icon
992
AeroVironment
AVAV
$7.81B
$196K ﹤0.01%
1,753
-86
-5% -$7.46K
LEA icon
993
Lear
LEA
$7.26B
$196K ﹤0.01%
1,357
-113,116
-99% -$19.4M
BAC.PRL icon
994
Bank of America Series L
BAC.PRL
$3.97B
$194K ﹤0.01%
150
+65
+76% +$83.4K
CHRD icon
995
Chord Energy
CHRD
$7.42B
$194K ﹤0.01%
13,697
+1,217
+10% +$15.4K
TFCFA
996
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$194K ﹤0.01%
4,218
-2,700
-39% -$124K
MLAB icon
997
Mesa Laboratories
MLAB
$540M
$193K ﹤0.01%
1,050
MSEX icon
998
Middlesex Water
MSEX
$1.05B
$193K ﹤0.01%
4,000
-1,500
-27% -$68.4K
WFC.PRL icon
999
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.68B
$193K ﹤0.01%
150
+55
+58% +$70.2K
MTD icon
1000
Mettler-Toledo International
MTD
$27B
$192K ﹤0.01%
316
-39,256
-99% -$23.1M

Similar funds

Glenmede Trust's Q3 2018 Portfolio in Review

As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.

  • Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
  • Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
  • Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
  • Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
  • Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
  • Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
  • Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.

Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.